Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
Bleomycin (BLM) is an effective curative option in the management of several malignancies including pleural effusions; but pulmonary toxicity, comprising of pneumonitis and fibrosis, poses challenge in its use as a front-line chemotherapeutic. Although Amifostine has been found to protect lungs from...
Main Authors: | Aastha Arora, Vikas Bhuria, Puja P. Hazari, Uma Pathak, Sweta Mathur, Bal G. Roy, Rajat Sandhir, Ravi Soni, Bilikere S. Dwarakanath, Anant N. Bhatt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2018.00394/full |
Similar Items
-
Effect of Amifostine on Locally Advanced Non-small Cell Lung Cancer Patients Treated with Radiotherapy: A Meta-analysis of Randomized Controlled Trials
by: Shengye WANG, et al.
Published: (2012-09-01) -
Amifostine- and chemoradiotherapy-related esophagitis in small cell lung cancer: a single institutional series and literature update
by: Pollock AE, et al.
Published: (2018-09-01) -
Preclinical investigation of the pharmacokinetics, metabolism, and protein and red blood cell binding of DRDE-07: a prophylactic agent against sulphur mustard
by: Pankaj Verma, et al.
Published: (2014-10-01) -
A case of bleomycin-induced lung toxicity
by: Cuneyt Tetikkurt, et al.
Published: (2018-11-01) -
The Protective Effect of Amifostine on Radiation-Induced Proctitis: Systemic Versus Topical Application
by: Cem Uzal, et al.
Published: (2012-03-01)